4-Iodo-N-(pyrazin-2-yl)benzamide

Catalog No.: 
ACQWPS294
CAS No.: 
1250516-70-1
Molecular Formula: 
C11H8IN3O
Molecular Weight: 
325.11
4-Iodo-N-(pyrazin-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$260.00InquiryInquiry
100mg98%$380.00InquiryInquiry
250mg98%$536.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Iodo-N-(pyrazin-2-yl)benzamide
IUPAC Name4-iodo-N-(pyrazin-2-yl)benzamide
MDL No.MFCD14647230
Molecular FormulaC11H8IN3O
Molecular Weight325.11
SMILESO=C(NC1=NC=CN=C1)C2=CC=C(I)C=C2
InChI KeyULPASYKADJIJTN-UHFFFAOYSA-N
Synonym4-iodo-N-(pyrazin-2-yl)benzamide;Benzamide, 4-iodo-N-2-pyrazinyl-
CAS No.1250516-70-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQWPS294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXHO721 route compound structure diagram
    ACFXHO7215049-61-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQWPS294 route product structure diagram
    ACQWPS2941250516-70-1
Inquiry

2. ACQWPS294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXHO721 route compound structure diagram
    ACFXHO7215049-61-6In Stock
  2. Plus
  3. ACBLYH147 route compound structure diagram
    ACBLYH147619-58-9In Stock
  4. Then
  5. ACQWPS294 route product structure diagram
    ACQWPS2941250516-70-1
Inquiry

3. ACQWPS294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXHO721 route compound structure diagram
    ACFXHO7215049-61-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQWPS294 route product structure diagram
    ACQWPS2941250516-70-1
Inquiry

Comments (0)